Concourse Financial Group Securities, Inc. Entera Bio Ltd. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENTX
# of Institutions
25Shares Held
10.8MCall Options Held
21.1KPut Options Held
0-
Knoll Capital Management, LLC Miami, FL5.88MShares$15.9 Million6.34% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.18MShares$3.19 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0627KShares$1.7 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY567KShares$1.54 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT281KShares$761,0270.07% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $78.1M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...